GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (BOM:590006) » Definitions » Cash And Cash Equivalents

Amrutanjan Health Care (BOM:590006) Cash And Cash Equivalents : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Amrutanjan Health Care Cash And Cash Equivalents?

Amrutanjan Health Care's quarterly cash and cash equivalents increased from Jun. 2023 (₹0.00 Mil) to Sep. 2023 (₹92.60 Mil) but then stayed the same from Sep. 2023 (₹92.60 Mil) to Dec. 2023 (₹0.00 Mil).

Amrutanjan Health Care's annual cash and cash equivalents declined from Mar. 2021 (₹1,306.98 Mil) to Mar. 2022 (₹834.85 Mil) and declined from Mar. 2022 (₹834.85 Mil) to Mar. 2023 (₹49.03 Mil).


Amrutanjan Health Care Cash And Cash Equivalents Historical Data

The historical data trend for Amrutanjan Health Care's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care Cash And Cash Equivalents Chart

Amrutanjan Health Care Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 733.82 271.58 1,306.98 834.85 49.03

Amrutanjan Health Care Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 49.03 - 92.60 -

Amrutanjan Health Care Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Amrutanjan Health Care  (BOM:590006) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Amrutanjan Health Care Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Amrutanjan Health Care (BOM:590006) Business Description

Traded in Other Exchanges
Address
No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (BOM:590006) Headlines

No Headlines